Loading stock…

HCA Healthcare, Inc. (HCA) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

HCA Healthcare, Inc.

HCAMarket cap $94BPrice $432.2

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Operates 180+ hospitals across 20 states, making it America's largest for-profit hospital chain. Treats over 3 million patients annually and generates more revenue than Netflix, Starbucks, and Disney combined.

In Bastion Portfolios?

52W Return+2%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+8%6

Revenue Forecast

Rev CAGR (1y)+4%4

Rev CAGR (3y)+4%3

Rev CAGR (5y)+5%5

Earnings Forecast

EPS Growth Y+1+6%6

EPS Growth Y+2+2%4

EPS Growth Y+3+4%5

Quality

Margins

EBIT Margin15%6

Net Income Margin9%5

Free Cash Flow Margin8%5

Debt

Net Debt/EBITDA3.03

Efficiency

ROEna–

ROA13%9

Earnings Stability77

GEAR+AVERAGE54

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)146

P/E Ratio (Forward 3y)145

P/BVna–

EV Multiples

EV/EBITDA Fwd97

EV/EBIT Fwd127

Yield

Free Cash Flow Yield6.4%7

Dividend Yield0.7%2

Momentum

Short term

1 month return+7%10

3 month return+2%7

YTD return-7%4

Mid term

Price vs 52wHigh78%5

1 year return-1%5

Long term

3 year return+80%7

5 year return+86%7

Risk Shield

Price Risk

Beta0.39

Volatility31%7

Free Cash Flow

Free Cash Flow Margin8%5

Free Cash Flow Yield6.4%7

Quality

ROCE27%9

Earnings Stability77

Net Debt/EBITDA3.03

02Growth

Is it actually growing, and how fast?

HCAHCA Healthcare

Revenue FY25$75.6B

GROWTH RATING↗

WEAK34 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+8%6

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+6%6

EPS growth, FY27E+2%4

EPS growth, FY28E+4%5

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

A mid-pack grower, ahead of 34% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 8%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

Earnings are set to grow in step with sales (EPS about 4%/yr vs revenue 4%/yr).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG70 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+7%10

3-month return+2%7

YTD return-7%4

MID & LONG-TERM▾SCORE

% of 52-week high78%5

1-year return-1%5

3-year return+80%7

5-year return+86%7

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +80% over three years and +86% over five, ahead of 60% of the market.

Strong recent results. The stock is outperforming over the past month (+7%) and over three months (+2%).

WATCH

It's down 0.6% over the past year, now 22% below its 52-week high. That is right in line with the market.

Returns sit at the market level so far this year (-7%).

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on HCA. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

HCAHCA Healthcare

Revenue FY25$75.6B

GROWTH RATING↗

WEAK34 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+8%6

Revenue, next 1Y+4%4

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+6%6

EPS growth, FY27E+2%4

EPS growth, FY28E+4%5

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

A mid-pack grower, ahead of 34% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 8%/yr over the last 3 years; forecasts see it cooling to 4%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

Earnings are set to grow in step with sales (EPS about 4%/yr vs revenue 4%/yr).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG70 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+7%10

3-month return+2%7

YTD return-7%4

MID & LONG-TERM▾SCORE

% of 52-week high78%5

1-year return-1%5

3-year return+80%7

5-year return+86%7

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +80% over three years and +86% over five, ahead of 60% of the market.

Strong recent results. The stock is outperforming over the past month (+7%) and over three months (+2%).

WATCH

It's down 0.6% over the past year, now 22% below its 52-week high. That is right in line with the market.

Returns sit at the market level so far this year (-7%).

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on HCA. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community